Search:

Home Index Back issues Contact

 

Volume 7, Number 4

 

Chocolate or aspirin? Cocoa as thromboprophylactic agent

Louisa Brown MBBS Medical Student; Nichola Biggs MBBS Medical Student; Timothy Farren BSc (Hons) AIBMS Medical Laboratory Scientific Officer; Cedric Ghevaert MD MRCP DipRCPath Specialist Registrar in Haematology; Denise O’Shaughnessy DPhil MBA FRCP FRCPath Consultant Haematologist, Southampton General Hospital, Southampton

Cocoa has recently been shown to have an antiplatelet activity. It is thought that this effect is mediated by the flavonoids contained in chocolate, which have aspirin-like properties. If these findings are confirmed, chocolate could potentially be used as an alternative to aspirin in thromboprophylaxis. This idea would be especially attractive in situations such as deep vein thrombosis (DVT) prevention in air passengers.

 

The anticoagulated patient undergoing dental surgery

Pippa K Blacklock FDSRCS Staff Grade, Department of Oral and Maxillofacial Surgery, Derriford Hospital, Plymouth

Many of the large numbers of patients on warfarin still have their own dentition and continue to require dental treatment. However, recent changes in guidelines and differences in advice offered by the varied involved specialties often leads to confusion and a lack of consensus in the management of this group of patients.

 

Venous thromboembolic events and malignancy – a varied approach

Myles Bradbury MRCPCH Specialist Registrar Haematology, City Hospital, Birmingham

Venous thromboembolism (VTE) is a common problem in patients with malignancy and is a significant cause of morbidity and mortality. It also appears to be a more aggressive disease process when compared with thrombosis in patients without malignancy. Despite its negative effect on outcome, the perceived risk, prevention and treatment of VTE varies among different specialties treating malignancy and among peers.

 

Thrombosis in PNH and PV

Peter Rose, Editor

Just as most physicians can recall the only case of phaeochromocytoma presented to them, so most haematologists find immense satisfaction in diagnosing paroxysmal nocturnal haemoglobinuria (PNH).

 

Beware the superwarfarins

Malcolm Tait FCPATH (Haem) SA Haematologist, University Hospitals, Warwick and Coventry

With the number of rodents increasing during summer and with the extended period of warm weather experienced in the UK last summer, there has been a significant increase in the rodent population. Consequently, the use of rodenticides has risen, with an estimated 70% of UK farms now using them.

 

 


The data, opinions and statements appearing in the articles herein are those of the contributor(s) concerned; they are not necessarily endorsed by the sponsors, publisher, Editor or Editorial Board. Accordingly the sponsors, publisher, Editor and Editorial Board and their respective employees, officers and agents accept no liability for the consequences of any such inaccurate or misleading data, opinion or statement.
Copyright (©) 2010 Hayward Group Ltd. The title Thrombus is the property of Hayward Group Ltd and, together with the content, is bound by copyright. The information contained on the site may not be reproduced, distributed or published, in whole or in part, in any form without the permission of the publishers. All correspondence should be addressed to: admin@hayward.co.uk